<!DOCTYPE html>
<html lang="en"><head>
<script src="../../site_libs/clipboard/clipboard.min.js"></script>
<script src="../../site_libs/quarto-html/tabby.min.js"></script>
<script src="../../site_libs/quarto-html/popper.min.js"></script>
<script src="../../site_libs/quarto-html/tippy.umd.min.js"></script>
<link href="../../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../../site_libs/quarto-html/light-border.css" rel="stylesheet">
<link href="../../site_libs/quarto-html/quarto-syntax-highlighting-549806ee2085284f45b00abea8c6df48.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.6.40">

  <meta name="author" content="Anish S. Shah, MD, MS">
  <meta name="dcterms.date" content="2025-02-12">
  <title>Clinical – Left Atrial Occlusion Devices and Stroke Risk</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="../../site_libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="../../site_libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
    /* CSS for citations */
    div.csl-bib-body { }
    div.csl-entry {
      clear: both;
      margin-bottom: 0em;
    }
    .hanging-indent div.csl-entry {
      margin-left:2em;
      text-indent:-2em;
    }
    div.csl-left-margin {
      min-width:2em;
      float:left;
    }
    div.csl-right-inline {
      margin-left:2em;
      padding-left:1em;
    }
    div.csl-indent {
      margin-left: 2em;
    }  </style>
  <link rel="stylesheet" href="../../site_libs/revealjs/dist/theme/quarto-8b6eb61e83515d3a03c79fc1d4596e96.css">
  <link href="../../site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="../../site_libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="../../site_libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="../../site_libs/revealjs/plugin/reveal-attribution/attribution.css" rel="stylesheet">
  <link href="../../site_libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
  <script src="../../site_libs/quarto-diagram/mermaid-postprocess-shim.js"></script>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Left Atrial Occlusion Devices and Stroke Risk</h1>
  <p class="subtitle">Journal Club</p>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Anish S. Shah, MD, MS 
</div>
        <p class="quarto-title-affiliation">
            Division of Cardiology, Department of Medicine, University of Utah
          </p>
    </div>
</div>

  <p class="date">2025-02-12</p>
</section>
<section id="who-watches-the-watchmen" class="title-slide slide level1 center">
<h1>Who Watches the Watchmen?</h1>
<div class="fragment">
<p>“Quis custodiet ipsos custodes?” ~ <em>Satires</em> by Juvenal</p>
</div>
</section>

<section>
<section id="introduction" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>Introduction</h1>

</section>
<section id="objectives" class="slide level2 smaller">
<h2>Objectives</h2>
<ol type="a">
<li class="fragment">Understand the landscape of stroke risk in AF</li>
<li class="fragment">Identify the competing and supporting roles of pharmalogical and device therapy</li>
<li class="fragment">Consider the standard-of-care and non-inferior (and superiority) in novel stroke mitigation strategies</li>
<li class="fragment">Ponder the risk/reward analysis in left atrial appendage occlusion strategies as part of AF rhythm management</li>
</ol>
<div title="Disclaimer">
<div class="callout callout-important callout-titled callout-style-default">
<div class="callout-body">
<div class="callout-title">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<p><strong>Disclaimer</strong></p>
</div>
<div class="callout-content">
<p>The focus is on non-valvular AF, and does not consider the differential risk in patients with inflammatory atrial myopathies or severe valve disease <span class="math inline">\(\pm\)</span> valve replacement).</p>
</div>
</div>
</div>
</div>
</section>
<section id="outline" class="slide level2">
<h2>Outline</h2>
<ol type="1">
<li class="fragment">Background of stroke risk</li>
<li class="fragment">Relevant left atrial anatomy and physiology</li>
<li class="fragment">Left atrial appendage occlusion devices</li>
<li class="fragment">Post-occlusion stroke risk</li>
<li class="fragment">Occlusion devices with pulmonary vein isolation</li>
</ol>
</section>
<section id="abbreviations" class="slide level2 smaller">
<h2>Abbreviations</h2>
<p><strong>AF</strong> = atrial fibrillation</p>
<p><strong>DRT</strong> = device-related thrombus</p>
<p><strong>LA</strong> = left atrium</p>
<p><strong>LAA</strong> = left atrial appendage</p>
<p><strong>LAAO</strong> = left atrial appendage occlusion</p>
<p><strong>pLAAO</strong> = percutaneous left atrial appendage occlusion</p>
<p><strong>PDL</strong> = peri-device leaks</p>
<p><strong>PVI</strong> = pulmonary vein isolation</p>
<p><strong>sLAAO</strong> = surgical left atrial appendage occlusion</p>
<p><strong>VKA</strong> = vitamin K antagonist (e.g.&nbsp;warfarin)</p>
</section></section>
<section>
<section id="background-on-stroke-risk-in-atrial-fibrillation" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>Background on Stroke Risk in Atrial Fibrillation</h1>

</section>
<section id="section" class="slide level2 smaller">
<h2></h2>
<div class="columns">
<div class="column" style="width:65%;">
<p><em>Do not account for additional risk factors, such as AF type or burden, smoking, obesity, kidney disease, other cardiac structural abnormalities.</em></p>
<ul>
<li class="fragment"><span class="math inline">\(CHA_{2}DS_{2}VASc\)</span> score</li>
<li class="fragment"><span class="math inline">\(ATRIA\)</span> score (Anticoagluation and Risk Factors in Atrial Fibrillation)</li>
<li class="fragment"><span class="math inline">\(GARFIELD-AF\)</span> (Global Anticoagulant Registry in the Field - Atrial Fibrillation)</li>
</ul>
</div><div class="column" style="width:35%;">
<div id="tbl-risk-categories" class="quarto-float quarto-figure quarto-figure-center">
<figure class="quarto-float quarto-float-tbl">
<div aria-describedby="tbl-risk-categories-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table>
<thead>
<tr class="header">
<th>Category</th>
<th>Absolute Risk</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Low</td>
<td>&lt;1%/year</td>
</tr>
<tr class="even">
<td>Intermediate</td>
<td>1-2%/year</td>
</tr>
<tr class="odd">
<td>High</td>
<td>&gt;2%/year</td>
</tr>
</tbody>
</table>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-tbl" id="tbl-risk-categories-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;1: General thromboembolism risk categories
</figcaption>
</figure>
</div>
</div></div>
<div class="attribution">
<p><span class="citation" data-cites="Joglar2024">Joglar et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</section>
<section id="chads_2-score" class="slide level2 smaller">
<h2><span class="math inline">\(CHADS_{2}\)</span> Score</h2>
<div class="columns">
<div class="column" style="width:50%;">
<ul>
<li class="fragment">C: Congestive heart failure (1 point)</li>
<li class="fragment">H: Hypertension (1 point)</li>
<li class="fragment">A: Age ≥75 (1 point)</li>
<li class="fragment">D: Diabetes mellitus (1 point)</li>
<li class="fragment">S: Stroke/TIA/thromboembolism (2 points)</li>
</ul>
</div><div class="column" style="width:50%;">
<table>
<thead>
<tr class="header">
<th style="text-align: center;">Score</th>
<th style="text-align: center;">Estimated Annual Stroke Risk</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">0</td>
<td style="text-align: center;">1-2%</td>
</tr>
<tr class="even">
<td style="text-align: center;">1</td>
<td style="text-align: center;">3%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">2</td>
<td style="text-align: center;">4%</td>
</tr>
<tr class="even">
<td style="text-align: center;">3</td>
<td style="text-align: center;">6%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">4</td>
<td style="text-align: center;">9%</td>
</tr>
<tr class="even">
<td style="text-align: center;">5</td>
<td style="text-align: center;">12%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">6</td>
<td style="text-align: center;">18%</td>
</tr>
</tbody>
</table>
</div></div>
</section>
<section id="cha_2ds_2vasc-score" class="slide level2 smaller">
<h2><span class="math inline">\(CHA_{2}DS_{2}VASc\)</span> Score</h2>
<div class="columns">
<div class="column" style="width:50%;">
<ul>
<li class="fragment">C: Congestive heart failure (1 point)</li>
<li class="fragment">H: Hypertension (1 point)</li>
<li class="fragment">A₂: Age ≥ 75 (2 points)</li>
<li class="fragment">D: Diabetes mellitus (1 point)</li>
<li class="fragment">S₂: Stroke/TIA/thromboembolism (2 points)</li>
<li class="fragment">V: Vascular disease (e.g., prior MI, peripheral artery disease) (1 point)</li>
<li class="fragment">A: Age 65–74 (1 point)</li>
<li class="fragment">Sc: Sex category (female) (1 point)</li>
</ul>
</div><div class="column" style="width:50%;">
<table>
<thead>
<tr class="header">
<th style="text-align: center;">Score</th>
<th style="text-align: center;">Estimated Annual Stroke Risk</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">0</td>
<td style="text-align: center;">0%</td>
</tr>
<tr class="even">
<td style="text-align: center;">1</td>
<td style="text-align: center;">1%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">2</td>
<td style="text-align: center;">2%</td>
</tr>
<tr class="even">
<td style="text-align: center;">3</td>
<td style="text-align: center;">3%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">4</td>
<td style="text-align: center;">5%</td>
</tr>
<tr class="even">
<td style="text-align: center;">5</td>
<td style="text-align: center;">7%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">6</td>
<td style="text-align: center;">10%</td>
</tr>
<tr class="even">
<td style="text-align: center;">7</td>
<td style="text-align: center;">11%</td>
</tr>
<tr class="odd">
<td style="text-align: center;">8</td>
<td style="text-align: center;">11%</td>
</tr>
<tr class="even">
<td style="text-align: center;">9</td>
<td style="text-align: center;">12%</td>
</tr>
</tbody>
</table>
</div></div>
</section>
<section class="slide level2">

<div class="cell" data-fig-responsive="false" data-layout-align="center">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg aria-roledescription="timeline" role="graphics-document document" viewbox="0 0 1190 649.046875" style="; display: block; margin: auto auto auto auto" xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" width="NaN" id="mermaid-figure-1" height="NaN">
<style>#mermaid-figure-1{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#000000;}#mermaid-figure-1 .error-icon{fill:#552222;}#mermaid-figure-1 .error-text{fill:#552222;stroke:#552222;}#mermaid-figure-1 .edge-thickness-normal{stroke-width:1px;}#mermaid-figure-1 .edge-thickness-thick{stroke-width:3.5px;}#mermaid-figure-1 .edge-pattern-solid{stroke-dasharray:0;}#mermaid-figure-1 .edge-thickness-invisible{stroke-width:0;fill:none;}#mermaid-figure-1 .edge-pattern-dashed{stroke-dasharray:3;}#mermaid-figure-1 .edge-pattern-dotted{stroke-dasharray:2;}#mermaid-figure-1 .marker{fill:#666;stroke:#666;}#mermaid-figure-1 .marker.cross{stroke:#666;}#mermaid-figure-1 svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#mermaid-figure-1 p{margin:0;}#mermaid-figure-1 .edge{stroke-width:3;}#mermaid-figure-1 .section--1 rect,#mermaid-figure-1 .section--1 path,#mermaid-figure-1 .section--1 circle,#mermaid-figure-1 .section--1 path{fill:#555;}#mermaid-figure-1 .section--1 text{fill:#F4F4F4;}#mermaid-figure-1 .node-icon--1{font-size:40px;color:#F4F4F4;}#mermaid-figure-1 .section-edge--1{stroke:#555;}#mermaid-figure-1 .edge-depth--1{stroke-width:17;}#mermaid-figure-1 .section--1 line{stroke:#aaaaaa;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#F4F4F4;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-0 rect,#mermaid-figure-1 .section-0 path,#mermaid-figure-1 .section-0 circle,#mermaid-figure-1 .section-0 path{fill:#F4F4F4;}#mermaid-figure-1 .section-0 text{fill:#333;}#mermaid-figure-1 .node-icon-0{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-0{stroke:#F4F4F4;}#mermaid-figure-1 .edge-depth-0{stroke-width:14;}#mermaid-figure-1 .section-0 line{stroke:#0b0b0b;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-1 rect,#mermaid-figure-1 .section-1 path,#mermaid-figure-1 .section-1 circle,#mermaid-figure-1 .section-1 path{fill:#555;}#mermaid-figure-1 .section-1 text{fill:#F4F4F4;}#mermaid-figure-1 .node-icon-1{font-size:40px;color:#F4F4F4;}#mermaid-figure-1 .section-edge-1{stroke:#555;}#mermaid-figure-1 .edge-depth-1{stroke-width:11;}#mermaid-figure-1 .section-1 line{stroke:#aaaaaa;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#F4F4F4;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-2 rect,#mermaid-figure-1 .section-2 path,#mermaid-figure-1 .section-2 circle,#mermaid-figure-1 .section-2 path{fill:#BBB;}#mermaid-figure-1 .section-2 text{fill:#333;}#mermaid-figure-1 .node-icon-2{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-2{stroke:#BBB;}#mermaid-figure-1 .edge-depth-2{stroke-width:8;}#mermaid-figure-1 .section-2 line{stroke:#444444;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-3 rect,#mermaid-figure-1 .section-3 path,#mermaid-figure-1 .section-3 circle,#mermaid-figure-1 .section-3 path{fill:#777;}#mermaid-figure-1 .section-3 text{fill:#333;}#mermaid-figure-1 .node-icon-3{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-3{stroke:#777;}#mermaid-figure-1 .edge-depth-3{stroke-width:5;}#mermaid-figure-1 .section-3 line{stroke:#888888;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-4 rect,#mermaid-figure-1 .section-4 path,#mermaid-figure-1 .section-4 circle,#mermaid-figure-1 .section-4 path{fill:#999;}#mermaid-figure-1 .section-4 text{fill:#333;}#mermaid-figure-1 .node-icon-4{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-4{stroke:#999;}#mermaid-figure-1 .edge-depth-4{stroke-width:2;}#mermaid-figure-1 .section-4 line{stroke:#666666;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-5 rect,#mermaid-figure-1 .section-5 path,#mermaid-figure-1 .section-5 circle,#mermaid-figure-1 .section-5 path{fill:#DDD;}#mermaid-figure-1 .section-5 text{fill:#333;}#mermaid-figure-1 .node-icon-5{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-5{stroke:#DDD;}#mermaid-figure-1 .edge-depth-5{stroke-width:-1;}#mermaid-figure-1 .section-5 line{stroke:#222222;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-6 rect,#mermaid-figure-1 .section-6 path,#mermaid-figure-1 .section-6 circle,#mermaid-figure-1 .section-6 path{fill:#FFF;}#mermaid-figure-1 .section-6 text{fill:#333;}#mermaid-figure-1 .node-icon-6{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-6{stroke:#FFF;}#mermaid-figure-1 .edge-depth-6{stroke-width:-4;}#mermaid-figure-1 .section-6 line{stroke:#000000;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-7 rect,#mermaid-figure-1 .section-7 path,#mermaid-figure-1 .section-7 circle,#mermaid-figure-1 .section-7 path{fill:#DDD;}#mermaid-figure-1 .section-7 text{fill:#333;}#mermaid-figure-1 .node-icon-7{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-7{stroke:#DDD;}#mermaid-figure-1 .edge-depth-7{stroke-width:-7;}#mermaid-figure-1 .section-7 line{stroke:#222222;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-8 rect,#mermaid-figure-1 .section-8 path,#mermaid-figure-1 .section-8 circle,#mermaid-figure-1 .section-8 path{fill:#BBB;}#mermaid-figure-1 .section-8 text{fill:#333;}#mermaid-figure-1 .node-icon-8{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-8{stroke:#BBB;}#mermaid-figure-1 .edge-depth-8{stroke-width:-10;}#mermaid-figure-1 .section-8 line{stroke:#444444;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-9 rect,#mermaid-figure-1 .section-9 path,#mermaid-figure-1 .section-9 circle,#mermaid-figure-1 .section-9 path{fill:#999;}#mermaid-figure-1 .section-9 text{fill:#333;}#mermaid-figure-1 .node-icon-9{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-9{stroke:#999;}#mermaid-figure-1 .edge-depth-9{stroke-width:-13;}#mermaid-figure-1 .section-9 line{stroke:#666666;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-10 rect,#mermaid-figure-1 .section-10 path,#mermaid-figure-1 .section-10 circle,#mermaid-figure-1 .section-10 path{fill:#777;}#mermaid-figure-1 .section-10 text{fill:#333;}#mermaid-figure-1 .node-icon-10{font-size:40px;color:#333;}#mermaid-figure-1 .section-edge-10{stroke:#777;}#mermaid-figure-1 .edge-depth-10{stroke-width:-16;}#mermaid-figure-1 .section-10 line{stroke:#888888;stroke-width:3;}#mermaid-figure-1 .lineWrapper line{stroke:#333;}#mermaid-figure-1 .disabled,#mermaid-figure-1 .disabled circle,#mermaid-figure-1 .disabled text{fill:lightgray;}#mermaid-figure-1 .disabled text{fill:#efefef;}#mermaid-figure-1 .section-root rect,#mermaid-figure-1 .section-root path,#mermaid-figure-1 .section-root circle{fill:hsl(0, 0%, 70.6862745098%);}#mermaid-figure-1 .section-root text{fill:#333;}#mermaid-figure-1 .icon-container{height:100%;display:flex;justify-content:center;align-items:center;}#mermaid-figure-1 .edge{fill:none;}#mermaid-figure-1 .eventWrapper{filter:brightness(120%);}#mermaid-figure-1 :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}</style>
<g></g><g></g><defs><marker orient="auto" markerheight="4" markerwidth="6" refy="2" refx="5" id="mermaid-figure-1-arrowhead"><path d="M 0,0 V 4 L6,2 Z"></path></marker></defs><g transform="translate(100, 50)"><g class="timeline-node section--1"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h380 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="390" y1="67.3078125" x1="0" class="node-line--1"></line></g><g transform="translate(195, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">Warfarin Era</tspan></text></g></g></g><g transform="translate(100, 167.3078125)" class="taskWrapper"><g class="timeline-node section--1"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h180 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="190" y1="67.3078125" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">1980s</tspan></text></g></g></g><g class="lineWrapper"><line stroke-dasharray="5,5" marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="2" y2="599.0468719482421" x2="195" y1="234.61562500000002" x1="195"></line></g><g transform="translate(100, 367.3078125)" class="eventWrapper"><g class="timeline-node section--1"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">~7% CVA risk without</tspan><tspan dy="1.1em" x="0">medication</tspan></text></g></g></g><g transform="translate(100, 442.2156234741211)" class="eventWrapper"><g class="timeline-node section--1"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">4% with aspirin</tspan></text></g></g></g><g transform="translate(300, 167.3078125)" class="taskWrapper"><g class="timeline-node section--1"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h180 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="190" y1="67.3078125" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">1991</tspan></text></g></g></g><g class="lineWrapper"><line stroke-dasharray="5,5" marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="2" y2="599.0468719482421" x2="395" y1="234.61562500000002" x1="395"></line></g><g transform="translate(300, 367.3078125)" class="eventWrapper"><g class="timeline-node section--1"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">SPAF trial (aspirin v.</tspan><tspan dy="1.1em" x="0">warfarin)</tspan></text></g></g></g><g transform="translate(300, 442.2156234741211)" class="eventWrapper"><g class="timeline-node section--1"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line--1"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">2% with warfarin</tspan></text></g></g></g><g transform="translate(500, 50)"><g class="timeline-node section-0"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h580 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="590" y1="67.3078125" x1="0" class="node-line-0"></line></g><g transform="translate(295, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">DOAC Era</tspan></text></g></g></g><g transform="translate(500, 167.3078125)" class="taskWrapper"><g class="timeline-node section-0"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h180 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="190" y1="67.3078125" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">2009</tspan></text></g></g></g><g class="lineWrapper"><line stroke-dasharray="5,5" marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="2" y2="599.0468719482421" x2="595" y1="234.61562500000002" x1="595"></line></g><g transform="translate(500, 367.3078125)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">RE-LY Trial</tspan><tspan dy="1.1em" x="0">(dabigatran)</tspan></text></g></g></g><g transform="translate(500, 442.2156234741211)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">DOAC non-inferior</tspan></text></g></g></g><g transform="translate(700, 167.3078125)" class="taskWrapper"><g class="timeline-node section-0"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h180 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="190" y1="67.3078125" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">2011</tspan></text></g></g></g><g class="lineWrapper"><line stroke-dasharray="5,5" marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="2" y2="599.0468719482421" x2="795" y1="234.61562500000002" x1="795"></line></g><g transform="translate(700, 367.3078125)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">ARISTOTLE Trial</tspan><tspan dy="1.1em" x="0">(apixaban)</tspan></text></g></g></g><g transform="translate(700, 442.2156234741211)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">ROCKET-AF</tspan><tspan dy="1.1em" x="0">(rivaroxaban)</tspan></text></g></g></g><g transform="translate(700, 517.1234344482422)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">DOAC superior</tspan></text></g></g></g><g transform="translate(900, 167.3078125)" class="taskWrapper"><g class="timeline-node section-0"><g><path d="M0 62.3078125 v-57.3078125 q0,-5 5,-5 h180 q5,0 5,5 v62.3078125 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="67.3078125" x2="190" y1="67.3078125" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">2013</tspan></text></g></g></g><g class="lineWrapper"><line stroke-dasharray="5,5" marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="2" y2="599.0468719482421" x2="995" y1="234.61562500000002" x1="995"></line></g><g transform="translate(900, 367.3078125)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 59.90781097412109 v-54.90781097412109 q0,-5 5,-5 h180 q5,0 5,5 v59.90781097412109 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="64.90781097412109" x2="190" y1="64.90781097412109" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">ENGAGE AF-TIMI 48</tspan><tspan dy="1.1em" x="0">Trial (edoxaban)</tspan></text></g></g></g><g transform="translate(900, 442.2156234741211)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">DOAC non-inferior</tspan></text></g></g></g><g transform="translate(900, 502.2156234741211)" class="eventWrapper"><g class="timeline-node section-0"><g><path d="M0 45 v-40 q0,-5 5,-5 h180 q5,0 5,5 v45 H0 Z" class="node-bkg node-undefined" id="node-undefined"></path><line y2="50" x2="190" y1="50" x1="0" class="node-line-0"></line></g><g transform="translate(95, 10)"><text text-anchor="middle" dominant-baseline="middle" alignment-baseline="middle" dy="1em"><tspan dy="1em" x="0">1-2% with DOAC</tspan></text></g></g></g><g class="lineWrapper"><line marker-end="url(#mermaid-figure-1-arrowhead)" stroke="black" stroke-width="4" y2="284.615625" x2="1140" y1="284.615625" x1="50"></line></g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>
<div class="attribution">
<p><span class="citation" data-cites="Joglar2024">Joglar et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</section></section>
<section>
<section id="left-atrial-anatomy-and-physiology" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>Left Atrial Anatomy and Physiology</h1>

</section>
<section id="left-atrial-appendage" class="slide level2">
<h2>Left atrial appendage?</h2>
<ul>
<li class="fragment">Primordial atrium derivation from pulmonary bud fusion into the primitive LA</li>
<li class="fragment">LAA is 2-fold more compliant than LA, and acts like a decompression chamber (thus exclusion leads to decreased reservoir function)</li>
<li class="fragment">LAA also secretes majority of atrial natriuretic peptide</li>
</ul>
</section>
<section id="anatomy" class="slide level2 smaller">
<h2>Anatomy</h2>
<div class="columns">
<div class="column" style="width:40%;">
<div id="fig-laa-anatomy" class="quarto-float quarto-figure quarto-figure-center">
<figure class="quarto-float quarto-float-fig">
<div aria-describedby="fig-laa-anatomy-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<img data-src="garg-2024-laa-anatomy.png" class="img-fluid">
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-laa-anatomy-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;1: Diagram of LAA anatomy
</figcaption>
</figure>
</div>
</div><div class="column" style="width:60%;">
<ul>
<li class="fragment">Anatomical position:
<ul>
<li class="fragment">pulmonary arteries (superior)</li>
<li class="fragment">left ventricle free wall (inferomedial)</li>
<li class="fragment">left circumflex coronary artery (LAA ostium)</li>
<li class="fragment">left phrenic nerve (posterolateral)</li>
<li class="fragment">left superior pulmonary vein (posterior)</li>
<li class="fragment">mitral valve (inferior)</li>
</ul></li>
<li class="fragment">4 parts = ostium, neck, body, and tip</li>
<li class="fragment">Ostium is oval-shaped (can be triangular or teardrop)</li>
<li class="fragment">Body described by morphology: chicken wing, windsock, broccoli, cactus</li>
</ul>
</div></div>
</section>
<section class="slide level2">


<img data-src="garg-2024-laa-morphology.png" class="img-fluid r-stretch quarto-figure-center" id="fig-laa-morphology"><p class="caption">
Figure&nbsp;2: LAA examples using CT renderings, anatomical representations, and shape-based archetypes. Chicken wings are the most prominent, followed by cacti.
</p><div class="attribution">
<p><span class="citation" data-cites="Garg2024">Garg et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</section></section>
<section>
<section id="laao-devices" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>LAAO Devices</h1>

</section>
<section class="slide level2">


<img data-src="garg-2024-plaao-devices.png" class="img-fluid r-stretch quarto-figure-center" id="fig-plaao-devices"><p class="caption">
Figure&nbsp;3: Recent pLAAO device options, with most common devices now include Watchman FLX/FLX Pro and Amulet device
</p></section></section>
<section>
<section id="laao-stroke-risk" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>LAAO Stroke Risk</h1>

</section>
<section id="procedural-safety" class="slide level2 smaller">
<h2>Procedural safety</h2>
<ol type="1">
<li class="fragment"><em>EWOLUTION</em> by <span class="citation" data-cites="Turagam2019">Turagam et al. (<a href="#/references" role="doc-biblioref" onclick="">2019</a>)</span> (Watchman) <span class="math inline">\(\rightarrow\)</span> showed low ischemic stroke risk peri-procedurally without OAC therapy</li>
<li class="fragment"><em>PINNACLE FLX</em> by <span class="citation" data-cites="Kar2021">Kar et al. (<a href="#/references" role="doc-biblioref" onclick="">2021</a>)</span> (Watchman FLX) <span class="math inline">\(\rightarrow\)</span> showed 99% safety of implant and &lt;1% ischemic stroke risk (7 days of follow-up), with mean <span class="math inline">\(CHA_{2}DS_{2}VASc = 4\)</span></li>
</ol>
</section>
<section id="future-cva-risk" class="slide level2 smaller">
<h2>Future CVA risk</h2>
<ol type="1">
<li class="fragment"><em>ASAP</em> by <span class="citation" data-cites="Reddy2013">Reddy et al. (<a href="#/references" role="doc-biblioref" onclick="">2013</a>)</span> (Watchman) <span class="math inline">\(\rightarrow\)</span> pLAAO in those intolerant to VKA had reduced CVA risk from 7% (based on <span class="math inline">\(CHADS_{2}\)</span>) to 2%</li>
<li class="fragment"><em>PROTECT AF</em> by <span class="citation" data-cites="Reddy2014">Reddy et al. (<a href="#/references" role="doc-biblioref" onclick="">2014</a>)</span> (Watchman) <span class="math inline">\(\rightarrow\)</span> noninferiority RCT of pLAAO v. VKA, with pLAAO being <em>safer</em> than VKA, however low event rate and primary endpoints were composite MACE (e.g.&nbsp;ischemic stroke risk was 1.4 vs.&nbsp;1.1 events (per 100 patient-years) in device v. VKA)</li>
<li class="fragment"><em>PREVAIL</em> by <span class="citation" data-cites="Holmes2014">Holmes et al. (<a href="#/references" role="doc-biblioref" onclick="">2014</a>)</span> (Watchman) <span class="math inline">\(\rightarrow\)</span> non-inferiority between pLAAO and VKA, showing non-inferiority, mean <span class="math inline">\(CHADS_{2} = 2\)</span></li>
<li class="fragment"><em>PRAGUE-17</em> by <span class="citation" data-cites="Osmancik2020">Osmancik et al. (<a href="#/references" role="doc-biblioref" onclick="">2020</a>)</span> (Watchman, FLX, &amp; Amulet) <span class="math inline">\(\rightarrow\)</span> non-inferiority of pLAAO v. DOAC, with mean <span class="math inline">\(CHA_{2}DS_{2}VASc = 5\)</span></li>
</ol>
</section>
<section id="reduction-in-cva-risk" class="slide level2">
<h2>Reduction in CVA risk?</h2>
<p>Anticoagulation alone reduced CVA risk by 50-70%</p>
<div class="fragment">
<p>Difficult to ascertain true incidence because these scores likely <strong>underestimate</strong> risk.</p>
</div>
<div class="fragment">
<div class="r-fit-text">
<p>Does pLAAO truly reduce risk to 1-2%?</p>
</div>
</div>
</section>
<section id="device-complications" class="slide level2">
<h2>Device complications</h2>
<p>Peri-device leaks are generally described as residual communications between the LA and LAA body behind the LAAO device.</p>
<div class="fragment">
<p>Device-related thrombus is usually seen on any exposed metal hubs of pLAAO devices or exposed LA surfaces, and usually affected by the shape of that surface (e.g.&nbsp;differences between Amulet and Watchman).</p>
<div class="attribution">
<p><span class="citation" data-cites="Garg2024">Garg et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</div>
</section>
<section id="pdls" class="slide level2 smaller">
<h2>PDLs</h2>
<p>About a quarter of pLAAO had PDL at 1 year…</p>
<ul>
<li class="fragment">1st generation of pLAAO had rates of PDL between 30-40%</li>
<li class="fragment">2nd generation about 15%-20% risk (Watchman FLX)</li>
</ul>
<p>PDL usually categorized by size, with small being &lt;3 mm to &lt;5 mm in size.</p>
<div class="fragment">
<p><strong>PDLs increase the risk of ischemic stroke by ~2 fold</strong>, in follow-up data from the <em>NCDR LAAO Registry</em> and <em>PROTECT-AF</em></p>
<div class="attribution">
<p><span class="citation" data-cites="Alkhouli2023">Alkhouli et al. (<a href="#/references" role="doc-biblioref" onclick="">2023</a>)</span>; <span class="citation" data-cites="Dukkipati2022">Dukkipati et al. (<a href="#/references" role="doc-biblioref" onclick="">2022</a>)</span></p>
</div>
</div>
</section>
<section id="drts" class="slide level2 smaller">
<h2>DRTs</h2>
<p>Rates of DRT…</p>
<ul>
<li class="fragment">In <em>PROTECT-AF</em>, <em>PREVAIL</em>, and <em>CAP</em> registries was approximately 4% by 2 years</li>
<li class="fragment"><em>EUROC-DRT</em> approximately 18% in 1st year</li>
</ul>
<div class="fragment">
<p><strong>Increases risk of stroke by 3- to 5-fold, with 7-fold risk of hemorrhagic stroke</strong></p>
</div>
<div class="fragment">
<p>This was not seen in the <em>EWOLUTION</em> registry.</p>
<div class="attribution">
<p><span class="citation" data-cites="Dukkipati2018">Dukkipati et al. (<a href="#/references" role="doc-biblioref" onclick="">2018</a>)</span>; <span class="citation" data-cites="Alkhouli2018">Alkhouli et al. (<a href="#/references" role="doc-biblioref" onclick="">2018</a>)</span>; <span class="citation" data-cites="Turagam2019">Turagam et al. (<a href="#/references" role="doc-biblioref" onclick="">2019</a>)</span></p>
</div>
</div>
</section>
<section id="pdls-and-drts-in-cva-risk" class="slide level2">
<h2>PDLs and DRTs in CVA risk</h2>
<div class="fragment">
<div class="r-fit-text">
<p><strong>PDL increases the risk category for 25% of implants to the 2-3% CVA incidence </strong></p>
</div>
</div>
<div class="fragment">
<div class="r-fit-text">
<p><strong>DRT increases the risk category for 5-10% of implants to the 20-30% CVA incidence </strong></p>
</div>
</div>
<div class="fragment">
<p><em>Candidates for these studies were predominantly deemed to not be candidates for OAC, leading to increased bleeding risk if OAC was forced to be restarted.</em></p>
</div>
</section>
<section class="slide level2">


<img data-src="garg-2024-forest-plot.png" class="img-fluid r-stretch quarto-figure-center" id="fig-laao-hazard"><p class="caption">
Figure&nbsp;4: The risk of ischemic stroke favors that of OAC in the pooled results of <em>PROTECT-AF</em> and <em>PREVAIL</em>, but not powered to detect individual outcome differences
</p></section>
<section id="modifiable-factors" class="slide level2">
<h2>Modifiable factors?</h2>
<ul>
<li class="fragment">PDL can theoretically be sealed by plugs and RF energy</li>
<li class="fragment">Rhythm maintenance, with persistent AF increasing risk</li>
<li class="fragment">Implanting &gt; 1 cm deep from PV ridge</li>
</ul>
</section></section>
<section>
<section id="occlusion-devices-with-pvi" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>Occlusion Devices with PVI</h1>

</section>
<section id="coupling-of-procedures" class="slide level2">
<h2>Coupling of procedures</h2>
<ul>
<li class="fragment">Rhythm control with ablation does decrease stroke risk if sinus is maintained</li>
<li class="fragment">Device placement can make challenging ablation due to altered anatomy (not studied with PFA)</li>
<li class="fragment">LAA isolation can potentially reduce AF burden by removing potential trigger, however may worsen heart failure</li>
</ul>
</section>
<section id="option" class="slide level2">
<h2>OPTION</h2>
<ul>
<li class="fragment">RCT of n=1600 individuals after PVI to pLAAO v. OAC</li>
<li class="fragment">Mean <span class="math inline">\(CHA_{2}DS_{2}VASc = 3.5\)</span></li>
<li class="fragment">Primary safety end-point = major, non-procedural bleeding
<ul>
<li class="fragment">n=65 in pLAAO arm and n=137 in OAC arm</li>
</ul></li>
<li class="fragment">Primary efficacy end-point = ischemic stroke
<ul>
<li class="fragment">n=41 in pLAAO arm and n=44 in OAC arm</li>
</ul></li>
<li class="fragment">LAAO had lower bleeding rates, and similar thromboembolic rates</li>
</ul>
<div class="attribution">
<p><span class="citation" data-cites="Wazni2024">Wazni et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</section>
<section class="slide level2">


<img data-src="wazni-2024-consort-diagram.png" class="img-fluid r-stretch quarto-figure-center" id="fig-option-consort"><p class="caption">
Figure&nbsp;5: Patient flow diagram in randomization for LAAO vs.&nbsp;OAC after ablation
</p></section>
<section class="slide level2">


<img data-src="wazni-2024-baseline-characteristics.png" class="img-fluid r-stretch quarto-figure-center" id="fig-option-baseline"><p class="caption">
Figure&nbsp;6: Baseline characteristics
</p></section>
<section class="slide level2">


<img data-src="wazni-2024-outcomes.png" class="img-fluid r-stretch quarto-figure-center" id="fig-option-outcomes"><p class="caption">
Figure&nbsp;7: Outcomes based on KM estimates. Notably, they were comparing bleeding events in an arm <strong>not</strong> on a blood thinner versus an OAC arm.
</p></section>
<section id="combination" class="slide level2">
<h2>COMBINATION</h2>
<ul>
<li class="fragment">RCT of n=200 participants randomized to single-procedure PVI and pLAAO, with either pLAAO first or second</li>
<li class="fragment">Mean <span class="math inline">\(CHA_{2}DS_{2}VASc = 4\)</span></li>
<li class="fragment">Primary end-point = risk of ischemic stroke</li>
<li class="fragment">Secondary end-point = risk of AF recurrence</li>
<li class="fragment">If pLAAO was implanted first, risk of future AF and rates of PDL and DRT was lower</li>
</ul>
<div class="fragment">
<p>Feasibility and safety of combined procedure supported in by other groups (<span class="citation" data-cites="Preisendorfer2024">Preisendörfer et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span>).</p>
<div class="attribution">
<p><span class="citation" data-cites="Du2024">Du et al. (<a href="#/references" role="doc-biblioref" onclick="">2024</a>)</span></p>
</div>
</div>
</section>
<section class="slide level2">


<img data-src="du-2024-consort-diagram.png" class="img-fluid r-stretch quarto-figure-center" id="fig-combination-consort"><p class="caption">
Figure&nbsp;8: Patient flow for randomization
</p></section>
<section class="slide level2">


<img data-src="du-2024-baseline-characteristics.png" class="img-fluid r-stretch quarto-figure-center" id="fig-combination-baseline"><p class="caption">
Figure&nbsp;9: Baseline characteristics
</p></section>
<section class="slide level2">


<img data-src="du-2024-outcomes.png" class="img-fluid r-stretch quarto-figure-center" id="fig-combination-outcomes"><p class="caption">
Figure&nbsp;10: Procedural outcomes
</p></section>
<section class="slide level2">


<img data-src="du-2024-km-stroke-risk.png" class="img-fluid r-stretch quarto-figure-center" id="fig-combination-stroke-curves"><p class="caption">
Figure&nbsp;11: Survival curves for ischemic stroke risk
</p></section>
<section class="slide level2">


<img data-src="du-2024-km-af-risk.png" class="img-fluid r-stretch quarto-figure-center" id="fig-combination-af-curves"><p class="caption">
Figure&nbsp;12: Survival curves for future AF risk
</p></section>
<section id="considerations" class="slide level2 smaller">
<h2>Considerations</h2>
<ul>
<li class="fragment"><span class="math inline">\(CHA_{2}DS_{2}VASc \ge 4\)</span> to provide adequate stroke risk reduction</li>
<li class="fragment">Candidates for PVI with RF energy</li>
<li class="fragment">Ability to address acute PDL and reduce risk for DRT by acheiving sinus</li>
<li class="fragment">pLAAO before PFA ablation has not been well studied (complicated by catheter touching device struts)</li>
<li class="fragment">Ridge anatomy and edema with ablation</li>
<li class="fragment">pLAAO prior to ablation as first line strategy?</li>
<li class="fragment"><em>Authors for majority of trials are the same, with similar disclosures to Watchman and Amulet parent companies</em></li>
</ul>
</section></section>
<section>
<section id="conclusion" class="title-slide slide level1 center" data-background-color="#9c435d">
<h1>Conclusion</h1>

</section>
<section id="questions" class="slide level2">
<h2>Questions?</h2>
</section>
<section id="references" class="slide level2 smaller scrollable">
<h2>References</h2>
<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" data-line-spacing="2" role="list">
<div id="ref-Alkhouli2018" class="csl-entry" role="listitem">
Alkhouli, M., Busu, T., Shah, K., Osman, M., Alqahtani, F., &amp; Raybuck, B. (2018). Incidence and <span>Clinical Impact</span> of&nbsp;<span>Device-Related Thrombus Following&nbsp;Percutaneous Left&nbsp;Atrial&nbsp;Appendage Occlusion</span>: <span>A Meta-Analysis</span>. <em>JACC. Clinical Electrophysiology</em>, <em>4</em>(12), 1629–1637. <a href="https://doi.org/10.1016/j.jacep.2018.09.007">https://doi.org/10.1016/j.jacep.2018.09.007</a>
</div>
<div id="ref-Alkhouli2023" class="csl-entry" role="listitem">
Alkhouli, M., De, B. O., Ellis, C. R., Nielsen, -K. J. E., Sievert, H., Natale, A., Lakkireddy, D., &amp; Holmes, D. R. (2023). Peridevice <span>Leak After Left Atrial Appendage Occlusion</span>. <em>JACC: Cardiovascular Interventions</em>, <em>16</em>(6), 627–642. <a href="https://doi.org/10.1016/j.jcin.2022.12.006">https://doi.org/10.1016/j.jcin.2022.12.006</a>
</div>
<div id="ref-Du2024" class="csl-entry" role="listitem">
Du, X., Chu, H., Yang, B., Zhong, J., Ruan, Z., Chen, Q., Leng, B., Tao, S., Lai, H., Liang, J., Xie, R., Ye, P., Zhou, X., Li, Y., Li, J., Zhao, Y., Zou, C., Sun, H., Li, X., … COMBINATION Trial Investigators. (2024). Strategy <span>Optimization</span> for a <span>Combined Procedure</span> in <span>Patients With Atrial Fibrillation</span>: <span>The COMBINATION Randomized Clinical Trial</span>. <em>JAMA Network Open</em>, <em>7</em>(11), e2445084. <a href="https://doi.org/10.1001/jamanetworkopen.2024.45084">https://doi.org/10.1001/jamanetworkopen.2024.45084</a>
</div>
<div id="ref-Dukkipati2022" class="csl-entry" role="listitem">
Dukkipati, S. R., Holmes, D. R., Doshi, S. K., Kar, S., Singh, S. M., Gibson, D., Price, M. J., Natale, A., Mansour, M., Sievert, H., Houle, V. M., Allocco, D. J., &amp; Reddy, V. Y. (2022). Impact of <span>Peridevice Leak</span> on 5-<span>Year Outcomes After Left Atrial Appendage&nbsp;Closure</span>. <em>Journal of the American College of Cardiology</em>, <em>80</em>(5), 469–483. <a href="https://doi.org/10.1016/j.jacc.2022.04.062">https://doi.org/10.1016/j.jacc.2022.04.062</a>
</div>
<div id="ref-Dukkipati2018" class="csl-entry" role="listitem">
Dukkipati, S. R., Kar, S., Holmes, D. R., Doshi, S. K., Swarup, V., Gibson, D. N., Maini, B., Gordon, N. T., Main, M. L., &amp; Reddy, V. Y. (2018). Device-<span>Related Thrombus After Left Atrial Appendage Closure</span>. <em>Circulation</em>, <em>138</em>(9), 874–885. <a href="https://doi.org/10.1161/CIRCULATIONAHA.118.035090">https://doi.org/10.1161/CIRCULATIONAHA.118.035090</a>
</div>
<div id="ref-Garg2024" class="csl-entry" role="listitem">
Garg, J., Kabra, R., Gopinathannair, R., Di Biase, L., Wang, D. D., Saw, J., Hahn, R., Freeman, J. V., Ellis, C. R., &amp; Lakkireddy, D. (2024). State of the <span>Art</span> in <span>Left Atrial Appendage&nbsp;Occlusion</span>. <em>JACC. Clinical Electrophysiology</em>, S2405-500X(24)00932-0. <a href="https://doi.org/10.1016/j.jacep.2024.10.024">https://doi.org/10.1016/j.jacep.2024.10.024</a>
</div>
<div id="ref-Holmes2014" class="csl-entry" role="listitem">
Holmes, D. R., Kar, S., Price, M. J., Whisenant, B., Sievert, H., Doshi, S. K., Huber, K., &amp; Reddy, V. Y. (2014). Prospective randomized evaluation of the <span>Watchman Left Atrial Appendage Closure</span> device in patients with atrial fibrillation versus long-term warfarin therapy: The <span>PREVAIL</span> trial. <em>Journal of the American College of Cardiology</em>, <em>64</em>(1), 1–12. <a href="https://doi.org/10.1016/j.jacc.2014.04.029">https://doi.org/10.1016/j.jacc.2014.04.029</a>
</div>
<div id="ref-Joglar2024" class="csl-entry" role="listitem">
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., … Van Wagoner, D. R. (2024). 2023 <span>ACC</span>/<span>AHA</span>/<span>ACCP</span>/<span>HRS Guideline</span> for the <span>Diagnosis</span> and <span>Management</span> of <span>Atrial Fibrillation</span>: <span>A Report</span> of the <span>American College</span> of <span>Cardiology</span>/<span>American Heart Association Joint Committee</span> on <span>Clinical Practice Guidelines</span>. <em>Circulation</em>, <em>149</em>(1), e1–e156. <a href="https://doi.org/10.1161/CIR.0000000000001193">https://doi.org/10.1161/CIR.0000000000001193</a>
</div>
<div id="ref-Kar2021" class="csl-entry" role="listitem">
Kar, S., Doshi, S. K., Sadhu, A., Horton, R., Osorio, J., Ellis, C., Stone, J., Shah, M., Dukkipati, S. R., Adler, S., Nair, D. G., Kim, J., Wazni, O., Price, M. J., Asch, F. M., Holmes, D. R., Shipley, R. D., Gordon, N. T., Allocco, D. J., … PINNACLE FLX Investigators. (2021). Primary <span>Outcome Evaluation</span> of a <span>Next-Generation Left Atrial Appendage Closure Device</span>: <span>Results From</span> the <span>PINNACLE FLX Trial</span>. <em>Circulation</em>, <em>143</em>(18), 1754–1762. <a href="https://doi.org/10.1161/CIRCULATIONAHA.120.050117">https://doi.org/10.1161/CIRCULATIONAHA.120.050117</a>
</div>
<div id="ref-Osmancik2020" class="csl-entry" role="listitem">
Osmancik, P., Herman, D., Neuzil, P., Hala, P., Taborsky, M., Kala, P., Poloczek, M., Stasek, J., Haman, L., Branny, M., Chovancik, J., Cervinka, P., Holy, J., Kovarnik, T., Zemanek, D., Havranek, S., Vancura, V., Opatrny, J., Peichl, P., … PRAGUE-17 Trial Investigators. (2020). Left <span>Atrial Appendage Closure Versus Direct Oral Anticoagulants</span> in <span>High-Risk Patients With Atrial Fibrillation</span>. <em>Journal of the American College of Cardiology</em>, <em>75</em>(25), 3122–3135. <a href="https://doi.org/10.1016/j.jacc.2020.04.067">https://doi.org/10.1016/j.jacc.2020.04.067</a>
</div>
<div id="ref-Preisendorfer2024" class="csl-entry" role="listitem">
Preisendörfer, S., Ayub, M. T., Sheth, A., Jabbour, G. Y., Singh, M., Patel, C. P., Gada, H., Bhonsale, A., Dhande, M., Estes, N. A., Kancharla, K., Kliner, D. E., Makani, A., Naniwadekar, A., Shalaby, A., Singla, V., Voigt, A., Saba, S. F., &amp; Jain, S. K. (2024). Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: <span>A</span> real-world, propensity-matched analysis. <em>Journal of Cardiovascular Electrophysiology</em>, <em>35</em>(12), 2423–2431. <a href="https://doi.org/10.1111/jce.16466">https://doi.org/10.1111/jce.16466</a>
</div>
<div id="ref-Reddy2013" class="csl-entry" role="listitem">
Reddy, V. Y., Möbius-Winkler, S., Miller, M. A., Neuzil, P., Schuler, G., Wiebe, J., Sick, P., &amp; Sievert, H. (2013). Left atrial appendage closure with the <span>Watchman</span> device in patients with a contraindication for oral anticoagulation: The <span>ASAP</span> study (<span>ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology</span>). <em>Journal of the American College of Cardiology</em>, <em>61</em>(25), 2551–2556. <a href="https://doi.org/10.1016/j.jacc.2013.03.035">https://doi.org/10.1016/j.jacc.2013.03.035</a>
</div>
<div id="ref-Reddy2014" class="csl-entry" role="listitem">
Reddy, V. Y., Sievert, H., Halperin, J., Doshi, S. K., Buchbinder, M., Neuzil, P., Huber, K., Whisenant, B., Kar, S., Swarup, V., Gordon, N., Holmes, D., &amp; for the PROTECT AF Steering Committee and Investigators. (2014). Percutaneous <span>Left Atrial Appendage Closure</span> vs <span>Warfarin</span> for <span>Atrial Fibrillation</span>: <span>A Randomized Clinical Trial</span>. <em>JAMA</em>, <em>312</em>(19), 1988–1998. <a href="https://doi.org/10.1001/jama.2014.15192">https://doi.org/10.1001/jama.2014.15192</a>
</div>
<div id="ref-Turagam2019" class="csl-entry" role="listitem">
Turagam, M. K., Reddy, V. Y., &amp; Dukkipati, S. R. (2019). <span>EWOLUTION</span> of <span>Watchman Left Atrial Appendage Closure</span> to <span>Patients With Contraindication</span> to <span>Oral Anticoagulation</span>. <em>Circulation: Arrhythmia and Electrophysiology</em>, <em>12</em>(4), e007257. <a href="https://doi.org/10.1161/CIRCEP.119.007257">https://doi.org/10.1161/CIRCEP.119.007257</a>
</div>
<div id="ref-Wazni2024" class="csl-entry" role="listitem">
Wazni, O. M., Saliba, W. I., Nair, D. G., Marijon, E., Schmidt, B., Hounshell, T., Ebelt, H., Skurk, C., Oza, S., Patel, C., Kanagasundram, A., Sadhu, A., Sundaram, S., Osorio, J., Mark, G., Gupta, M., DeLurgio, D. B., Olson, J., Nielsen-Kudsk, J. E., … Reddy, V. Y. (2024). Left <span>Atrial Appendage Closure</span> after <span>Ablation</span> for <span>Atrial Fibrillation</span>. <em>New England Journal of Medicine</em>, NEJMoa2408308. <a href="https://doi.org/10.1056/NEJMoa2408308">https://doi.org/10.1056/NEJMoa2408308</a>
</div>
</div>


</section></section>
    </div>
  <div class="quarto-auto-generated-content" style="display: none;">
<div class="footer footer-default">

</div>
</div></div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="../../site_libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="../../site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="../../site_libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="../../site_libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="../../site_libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="../../site_libs/revealjs/plugin/reveal-attribution/attribution.js"></script>
  <script src="../../site_libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="../../site_libs/revealjs/plugin/notes/notes.js"></script>
  <script src="../../site_libs/revealjs/plugin/search/search.js"></script>
  <script src="../../site_libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="../../site_libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease-in-out",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': false,
'jumpToSlide': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleScrollView(event)\"><kbd>r</kbd> Scroll View Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'h.v',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'default',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'fade',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'fast',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, RevealAttribution, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const onCopySuccess = function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      }
      const getTextToCopy = function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
        text: getTextToCopy
      });
      clipboard.on('success', onCopySuccess);
      if (window.document.getElementById('quarto-embedded-source-code-modal')) {
        const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
          text: getTextToCopy,
          container: window.document.getElementById('quarto-embedded-source-code-modal')
        });
        clipboardModal.on('success', onCopySuccess);
      }
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp('/' + window.location.host + '/');
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>